Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

1.3K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.3K
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

4.8K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
4.8K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

1.2K
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.2K
Dialysis01:27

Dialysis

1.7K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.7K
Dialysis01:15

Dialysis

2.0K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.0K
Peritoneum01:21

Peritoneum

10.8K
The peritoneum is a vital membrane that lines the abdominal cavity and covers most of the organs within it. It plays a crucial role in protecting the organs, providing a smooth surface for their movement, and facilitating various physiological processes. Understanding the anatomy and function of the peritoneum is essential for comprehending the complexities of the abdominal region.
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
10.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of serum myokine profile on the outcome of peritoneal dialysis patients.

BMC nephrology·2026
Same author

Triglyceride-glucose index and the outcome of peritoneal dialysis patients: analysis of two cohorts.

BMC nephrology·2026
Same author

Modified creatinine index as a noninvasive tool for the monitoring of muscle mass in peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Zinc alpha-2-glycoprotein in peritoneal dialysis effluent correlates with peritoneal transport characteristics, peritonitis rate, and outcome.

Kidney research and clinical practice·2026
Same author

Acute coronary syndrome is associated with acute kidney injury on admission but not during hospital stay.

Renal failure·2026
Same author

Body roundness Index on the clinical outcome of peritoneal dialysis patients: Analysis of two cohorts.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026

Related Experiment Video

Updated: Mar 8, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K

Inflammation and Peritoneal Dialysis.

Philip Kam-Tao Li1, Jack Kit-Chung Ng1, Christopher William Mcintyre2

  • 1Carol and Richard Yu Peritoneal Dialysis Research Centre, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.

Seminars in Nephrology
|February 4, 2017
PubMed
Summary
This summary is machine-generated.

Inflammation is a key risk factor for cardiovascular issues in peritoneal dialysis (PD) patients. This review explores inflammation causes, effects, and potential therapies for PD patients.

Keywords:
Inflammationadipokinescardiovascularendotoxinperitoneal dialysis

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K
A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

2.3K

Related Experiment Videos

Last Updated: Mar 8, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.1K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K
A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

2.3K

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Immunology

Background:

  • Inflammation is a significant risk factor for cardiovascular mortality in peritoneal dialysis (PD) patients.
  • Elevated C-reactive protein and interleukin-6 levels indicate inflammatory burden and predict poor outcomes in PD.
  • Causes of inflammation in PD are multifactorial, stemming from decreased renal function and dialysis-related factors.

Purpose of the Study:

  • To review the causes and clinical implications of inflammation in PD patients.
  • To explore therapeutic strategies targeting the pathogenic mechanisms of inflammation in PD.

Main Methods:

  • Literature review of studies on inflammation in PD patients.
  • Analysis of factors contributing to systemic and intraperitoneal inflammation.
  • Discussion of clinical outcomes and therapeutic interventions.

Main Results:

  • Inflammation in PD patients arises from complex interactions between renal decline and dialysis procedures.
  • Systemic and intraperitoneal inflammation contribute to adverse cardiovascular events.
  • Various therapeutic targets for managing inflammation in PD are identified.

Conclusions:

  • Understanding the origins of inflammation is crucial for managing PD patients.
  • Targeting inflammatory pathways offers potential for improving cardiovascular outcomes in PD.
  • Further research into novel anti-inflammatory therapies is warranted for PD patients.